脑部放疗,上午比下午敏感许多!- F; \7 h4 V- E1 s5 ~% e& l5 F
* }1 m$ d# Z/ z" l# P, V8 L( W
5 n" T# \, \4 eCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
0 S1 O9 { N9 d) v# N& gGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?" P; d( O, ]4 Q$ Q- H7 ]6 n
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., S# Z& ]* m( [0 r* ~
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA." Z7 H& h2 R" e- @+ L2 m
5 T$ J7 Z! b8 {2 ~1 CAbstract; r9 x5 Q. V/ K' d) v" E
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.( n" Y/ t" } h. P3 G! \2 A5 t2 \
6 I1 `' [ v+ v+ \8 ?5 V
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
K/ ]$ T- }# U/ }, z2 k* x2 o, g. p6 D+ K2 J
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).' s- \0 ]8 m" W3 L$ C! r4 F
. M% X. i+ ^6 O& ]+ B% h" [& d% q
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
1 s# l' v: e0 f' @8 A6 f* e' A. p+ F4 f5 D4 x m f7 T( h
|